Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 09:05:11 17/07/2025 pm IST			5-day change	1st Jan Change
34.25 ^GBX	+5.38%		+8.73%	-31.50%

17/07	Avacta Group Raises GBP3 Million via Share Placement Offer	MT
17/07	Avacta announces equity fundraise of £3.25 mln	RE

Press Releases

Avacta Group plc - Result of AGM	03/07	AQ
Avacta : AGM Business Update deck 2025	02/07	PU
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development	01/07	GL
Avacta : Appointment of Zeus Capital as Joint Broker to Avacta Group plc	30/06	PU
Avacta Therapeutics - New Response in the FAP-Dox Phase 1b Trial	20/06	AQ
Avacta : Preliminary Results for the Year Ended December 31, 2024 – Presentation deck	09/06	PU
Avacta : Annual Report and Accounts for the year ending December 31, 2024	06/06	PU
Avacta : Preliminary Results for the Year Ended December 31, 2024	06/06	PU
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors	28/05	GL
Avacta : Board appointments	28/05	PU
Avacta : Board change	29/04	PU
Avacta Therapeutics Presents Data from Lead pre\|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting	28/04	GL
Avacta Therapeutics Presents Preclinical and Translational Data from pre\|CISION® Platform Candidates at 2025 AACR Annual Meeting	28/04	GL
Avacta : R&D Spotlight Series, Episode 8	28/04	PU
Avacta : Therapeutics Presents Preclinical and Translational Data from pre\|CISION® Platform Candidates at 2025 AACR Annual Meeting	28/04	PU
Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives	31/03	GL
Avacta : Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives	31/03	PU
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting	26/03	GL
Avacta : Corporate Deck – March 2025	26/03	PU
Avacta : Therapeutics Announces Presentations at 2025 AACR Annual Meeting	26/03	PU
Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update	10/03	AQ
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference	10/03	GL
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts	07/03	GL
Avacta : R&D Spotlight Series, Episode 8	29/01	PU
Avacta : Corporate Deck – January 2025	23/01	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Press Releases

Filters